259 related articles for article (PubMed ID: 31992690)
21. PARP1 changes from three-dimensional DNA damage searching to one-dimensional diffusion after auto-PARylation or in the presence of APE1.
Liu L; Kong M; Gassman NR; Freudenthal BD; Prasad R; Zhen S; Watkins SC; Wilson SH; Van Houten B
Nucleic Acids Res; 2017 Dec; 45(22):12834-12847. PubMed ID: 29121337
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-Ribose) Polymerase 1 Promotes the Human Heat Shock Response by Facilitating Heat Shock Transcription Factor 1 Binding to DNA.
Fujimoto M; Takii R; Katiyar A; Srivastava P; Nakai A
Mol Cell Biol; 2018 Jul; 38(13):. PubMed ID: 29661921
[TBL] [Abstract][Full Text] [Related]
24. PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites.
Lin X; Jiang W; Rudolph J; Lee BJ; Luger K; Zha S
Nucleic Acids Res; 2022 Apr; 50(7):3958-3973. PubMed ID: 35349716
[TBL] [Abstract][Full Text] [Related]
25. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
Raspaglio G; Buttarelli M; Filippetti F; Battaglia A; Buzzonetti A; Scambia G; Gallo D
Cell Death Dis; 2021 Oct; 12(10):933. PubMed ID: 34642300
[TBL] [Abstract][Full Text] [Related]
26. PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention.
Zhu X; Ma X; Hu Y
Curr Med Chem; 2016; 23(17):1756-74. PubMed ID: 25245372
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.
Rajawat J; Shukla N; Mishra DP
Med Res Rev; 2017 Nov; 37(6):1461-1491. PubMed ID: 28510338
[TBL] [Abstract][Full Text] [Related]
28. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
[TBL] [Abstract][Full Text] [Related]
30. Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.
Ding X; Ray Chaudhuri A; Callen E; Pang Y; Biswas K; Klarmann KD; Martin BK; Burkett S; Cleveland L; Stauffer S; Sullivan T; Dewan A; Marks H; Tubbs AT; Wong N; Buehler E; Akagi K; Martin SE; Keller JR; Nussenzweig A; Sharan SK
Nat Commun; 2016 Aug; 7():12425. PubMed ID: 27498558
[TBL] [Abstract][Full Text] [Related]
31. New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.
Folk WP; Kumari A; Iwasaki T; Cassimere EK; Pyndiah S; Martin E; Homlar K; Sakamuro D
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948122
[TBL] [Abstract][Full Text] [Related]
32. PARP1 promotes gene expression at the post-transcriptiona level by modulating the RNA-binding protein HuR.
Ke Y; Han Y; Guo X; Wen J; Wang K; Jiang X; Tian X; Ba X; Boldogh I; Zeng X
Nat Commun; 2017 Mar; 8():14632. PubMed ID: 28272405
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the Complexes Formed between PARP1 Inhibitors and PARP1 G-Quadruplex at the Gene Promoter Region.
Dallavalle S; Princiotto S; Mattio LM; Artali R; Musso L; Aviñó A; Eritja R; Pisano C; Gargallo R; Mazzini S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445442
[TBL] [Abstract][Full Text] [Related]
34. Identification of PARP-1, Histone H1 and SIRT-1 as New Regulators of Breast Cancer-Related Aromatase Promoter I.3/II.
Kaiser A; Krüger T; Eiselt G; Bechler J; Kniemeyer O; Huber O; Schmidt M
Cells; 2020 Feb; 9(2):. PubMed ID: 32059481
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
36. Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells.
Maruyama T; Nara K; Yoshikawa H; Suzuki N
Clin Exp Immunol; 2007 Jan; 147(1):164-75. PubMed ID: 17177976
[TBL] [Abstract][Full Text] [Related]
37. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Jain PG; Patel BD
Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of PARP1 Increases IRF-dependent Gene Transcription in Jurkat Cells.
Wang C; Du M; Huang D; Huang K; Huang K
Curr Med Sci; 2019 Jun; 39(3):356-362. PubMed ID: 31209803
[TBL] [Abstract][Full Text] [Related]
39. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
[TBL] [Abstract][Full Text] [Related]
40. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
Ali R; Alabdullah M; Alblihy A; Miligy I; Mesquita KA; Chan SY; Moseley P; Rakha EA; Madhusudan S
Cancer Lett; 2020 Jan; 469():124-133. PubMed ID: 31669203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
